Detalhe da pesquisa
1.
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.
Br J Haematol
; 196(3): 639-648, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671975
2.
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.
Invest New Drugs
; 38(5): 1448-1453, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125598
3.
Trends in the use of therapeutic plasma exchange in multiple myeloma.
J Clin Apher
; 35(4): 307-315, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516865
4.
NEW-ONSET CARDIAC AMYLOIDOSIS WHILE IN REMISSION FROM SYSTEMIC AL AMYLOIDOSIS.
Eur J Case Rep Intern Med
; 10(2): 003768, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970162
5.
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial.
Hemasphere
; 7(3): e843, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36860268
6.
Melphalan flufenamide for relapsed/refractory multiple myeloma.
Drugs Today (Barc)
; 58(8): 407-423, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35983927
7.
Can Donor-Derived Cell-Free DNA Detect Graft-Versus-Host Disease in Solid Organ Transplantation: A Case Report.
Transplant Proc
; 54(1): 176-179, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961600
8.
Exercise, cancer and cardiovascular disease: what should clinicians advise?
Cardiovasc Endocrinol Metab
; 10(2): 62-71, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34113793
9.
Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
NPJ Genom Med
; 6(1): 23, 2021 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731690
10.
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
J Clin Oncol
; 39(7): 757-767, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296242
11.
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma.
Blood Rev
; 41: 100643, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818702
12.
Melflufen for relapsed and refractory multiple myeloma.
Expert Opin Investig Drugs
; 29(10): 1069-1078, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32924646
13.
Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma.
Int J Nephrol
; 2018: 4654717, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30254762
14.
Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities.
Expert Rev Hematol
; 11(12): 957-973, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339769
15.
Light Chain Amyloidosis Presenting as Bilateral External Auditory Canal Obstructing Masses.
Otol Neurotol
; 39(8): e749-e751, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29957672
16.
When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.
Clin Lymphoma Myeloma Leuk
; 19(6): e251-e258, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987953
17.
The Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (or Onco-Cardiology) and Call to Action.
J Am Coll Cardiol
; 72(2): 228-232, 2018 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976296